Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
MA02 - Improving Outcomes for Patients with Lung Cancer
- 10:30 - 12:00
- 9/24/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
-
+
MA02.05 - A Double-Blind, Randomized, Placebo-Controlled Phase 3 Noninferiority Study of Darbepoetin Alfa for Anemia in Advanced NSCLC
11:00 - 11:05 | Presenter: Rajnish Nagarkar | Author(s): Pere Gascón, Martin Šmakal, Kostas Syrigos, Carlos Barrios, Jesús Cárdenas Sánchez, Li Zhang, Dianne Tomita, Joseph Park, Cisio De Oliveira Brandao
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-106 - Pembrolizumab Randomized, Phase 1 Study in Chinese Patients with Advanced NSCLC: KEYNOTE-032.
16:45 - 18:00 | Presenter: Li Zhang | Author(s): Yuxiang Ma, Wenfeng Fang, Shuang Xie, Jun Ge, HaoJin Zhou
- Abstract
Loading... -
+
P1.01-107 - The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)
16:45 - 18:00 | Presenter: Li Zhang | Author(s): Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Baohui Han, Kai Li, Qiming Wang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Yinlan Chen, Jianying Zhou, Donglin Wang
- Abstract
Loading... -
+
P1.01-108 - Management of Anlotinib-Related Adverse Events: Data From ALTER 0303
16:45 - 18:00 | Presenter: Li Zhang | Author(s): Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Baohui Han, Kai Li, Qiming Wang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Yinlan Chen, Jianying Zhou, Donglin Wang
- Abstract
Loading... -
+
P1.01-109 - Phase I Study of Apatinib Plus Gefitinib as First-Line Therapy in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Hongyun Zhao | Author(s): Zhonghan Zhang, Su Li, Wenfeng Fang, Yuxiang Ma, Yang Zhang, Yunpeng Yang, Fan Luo, Yan Huang, Li Zhang
- Abstract
Loading... -
+
P1.01-110 - Three Specific HER2 Mutations Predict Favorable Outcomes in Advanced Lung Cancer Patients Treated with Afatinib
16:45 - 18:00 | Presenter: Shen Zhao | Author(s): Wenfeng Fang, Yunpeng Yang, Li Zhang
- Abstract
Loading...
-
+
P1.04 - Immunooncology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.04-02 - Targeting Established Lung Cancer Through Combination of DNT Cellular Therapy with PD1 Checkpoint Blockade
16:45 - 18:00 | Presenter: Linan Fang | Author(s): Dalam Ly, Wei Liu, Sisi Wang, Jong Lee, Heidi Kang, Li Zhang
- Abstract
Loading... -
+
P1.04-05 - Elucidating the Role of Leukocyte-Associated Immunoglobin-Like Receptor 2 (LAIR2) in Lung Cancer Development
16:45 - 18:00 | Presenter: Dalam Ly | Author(s): Michael Cabanero, Chang-Qi Zhu, Ming Sound Tsao, Li Zhang
- Abstract
Loading...
-
+
P1.15 - Treatment in the Real World - Support, Survivorship, Systems Research (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.15-17 - Risk Factors of Local Recurrence in EGFR-Mutant Stage III-pN2 Adenocarcinoma After Complete Resection: A Multi-Center Real-World Cohort Study
16:45 - 18:00 | Presenter: Hui Liu | Author(s): Qi-Wen Li, Bo Qiu, Wenhua Liang, Jun-Ye Wang, Wan-Ming Hu, Shuang-Bing Xu, Steven H Lin, José Luis López, Nai-Bin Chen, Tian Zhang, Minzhang Guo, Yi Zhao, Song-Ran Liu, Qianwen Liu, Jin-Yu Guo, Ling-Zhi Cai, Si-Yu Wang, Xin Wang, Lan-Jun Zhang, Tie-Hua Rong, Zhen-Tao Yu, Jing-Ping Yun, Gang Wu, Li Zhang, Vincent (Wentao) Fang, Hao Long, Qing-Song Pang
- Abstract
Loading...
-
+
P2.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.13-30 - High-Dose Icotinib in Advanced Non-Small Cell Lung Cancer with EGFR 21 L858R Mutation: The Randomized, Open-Label INCREASE Study
16:45 - 18:00 | Presenter: Shucai Zhang | Author(s): Xi Li, Li Zhang, Jiang Da, Yan Wang, Aimin Zang, Cuimin Ding, Min Zhao, Wuyun Su, Yan Zhang, Diansheng Zhong, Jin Wu, Guangyu An, Cuiying Zhang, Xingsheng Hu, Gang Cheng, Huaqing Wang, Zhihai Han, Xiaohui He, Junli Liu, Li Liang
- Abstract
Loading...
-
+
OA13 - Therapeutics and Radiation for Small Cell Lung Cancer
- 10:30 - 12:00
- 9/26/2018
- Location: Room 203 BD
- Type: Oral Abstract Session
- Track: Small Cell Lung Cancer/NET
-
+
OA13.06 - Final Report of a Prospective Randomized Study on Thoracic Radiotherapy Target Volumes in Limited-stage Small Cell Lung Cancer with Radiation Dosimetric and Pathologic Analyses
11:25 - 11:35 | Presenter: Xiao Hu | Author(s): Yong Bao, Yu Jin Xu, Hui Neng Zhu, Jin Shi Liu, Li Zhang, Xinmin Yu, Yun Fan, Yi Ping Zhang, Wen Yong Sun, Weimin Mao, Ming Chen
- Abstract
Loading...